EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring novel circulating biomarkers for liver cancer through extracellular vesicle characterization with infrared spectroscopy and plasmonics

R Di Santo, F Verdelli, B Niccolini, S Varca, A Del Gaudio, F Di Giacinto, M De Spirito, M Pea, E Giovine, A Notargiacomo, M Ortolani, A Di Gaspare und 3 weitere

Analytica Chimica Acta · 2024-08 · 1319 · 342959

DOI: 10.1016/j.aca.2024.342959 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024-08. Verfasst von R Di Santo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Neuroscienze, Sezione di Fisica, Università Cattolica del Sacro Cuore & Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rom…. Hauptthemen laut MEDLINE: Liver Neoplasms, Extracellular Vesicles, Biomarkers, Tumor, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondazione Umberto Veronesi, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hepatocellular carcinoma (HCC) is the most common form of liver cancer, with cirrhosis being a major risk factor. Traditional blood markers like alpha-fetoprotein (AFP) demonstrate limited efficacy in distinguishing between HCC and cirrhosis, underscoring the need for more effective diagnostic methodologies. In this context, extracellular vesicles (EVs) have emerged as promising candidates; however, their practical diagnostic application is restricted by the current lack of label-free methods to accurately profile their molecular content. To address this gap, our study explores the potential of mid-infrared (mid-IR) spectroscopy, both alone and in combination with plasmonic nanostructures, to detect and characterize circulating EVs. RESULTS: EVs were extracted from HCC and cirrhotic patients. Mid-IR spectroscopy in the Attenuated Total Reflection (ATR) mode was utilized to identify potential signatures for patient classification, highlighting significant changes in the Amide I-II region (1475-1700 cm-1). This signature demonstrated diagnostic performance comparable to AFP and surpassed it when the two markers were combined. Further investigations utilized a plasmonic metasurface suitable for ultrasensitive spectroscopy within this spectral range. This device consists of two sets of parallel rod-shaped gold nanoantennas (NAs); the longer NAs produced an intense near-field amplification in the Amide I-II bands, while the shorter NAs were utilized to provide a sharp reflectivity edge at 1800-2200 cm-1 for EV mass-sensing. A clinically relevant subpopulation of EVs was targeted by conjugating NAs with an antibody specific to Epithelial Cell Adhesion Molecule (EpCAM). This methodology enabled the detection of variations in the quantity of EpCAM-presenting EVs and revealed changes in the Amide I-II lineshape. SIGNIFICANCE: The presented results can positively impact the development of novel laboratory methods for the label-free characterization of EVs, based on the combination between mid-IR spectroscopy and plasmonics. Additionally, data obtained by using HCC and cirrhotic subjects as a model system, suggest that this approach could be adapted for monitoring these conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsExtracellular VesiclesBiomarkers, TumorCarcinoma, HepatocellularSpectrophotometry, InfraredHumansGoldEpithelial Cell Adhesion MoleculeMetal Nanoparticles

Substanzen

Biomarkers, TumorGoldEpithelial Cell Adhesion Molecule

Autor:innen und Institutionen

  • Dipartimento di Neuroscienze, Sezione di Fisica, Università Cattolica del Sacro Cuore & Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rome, Italy; Dipartimento di Scienze della Vita, della salute e delle Pro…
  • Dutch Institute for Fundamental Energy Research (DIFFER), Eindhoven 5600 HH, The Netherlands.
  • Dipartimento di Neuroscienze, Sezione di Fisica, Università Cattolica del Sacro Cuore & Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rome, Italy.
  • UOC of Gastroenterology, Department of Medical and Surgery Sciences, Fondazione Policlinico Universitario A.Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Dipartimento di Neuroscienze, Sezione di Fisica, Università Cattolica del Sacro Cuore & Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rome, Italy. Electronic address: marco.despirito@policlinicogemelli.it.
  • Istituto di Fotonica e Nanotecnologie, Consiglio Nazionale delle Ricerche IFN-CNR, Via Del Fosso Del Cavaliere 100, 00133, Rome, Italy.

Förderung

  • Fondazione Umberto Veronesi
  • Ministero della Salute

Zitieren

APA

Di Santo, R., Verdelli, F., Niccolini, B., Varca, S., Gaudio, A. D., Di Giacinto, F., De Spirito, M., Pea, M., Giovine, E., Notargiacomo, A., Ortolani, M., Di Gaspare, A., Baldi, A., Pizzolante, F., & Ciasca, G. (2024). Exploring novel circulating biomarkers for liver cancer through extracellular vesicle characterization with infrared spectroscopy and plasmonics. Analytica Chimica Acta, 1319, 342959. https://doi.org/10.1016/j.aca.2024.342959

Vancouver

Di Santo R, Verdelli F, Niccolini B, Varca S, Gaudio AD, Di Giacinto F, et al. Exploring novel circulating biomarkers for liver cancer through extracellular vesicle characterization with infrared spectroscopy and plasmonics. Analytica Chimica Acta. 2024;1319:342959. doi:10.1016/j.aca.2024.342959

BibTeX
@article{DiSanto2024,
  author = {Di Santo, R and Verdelli, F and Niccolini, B and Varca, S and Gaudio, A Del and Di Giacinto, F and De Spirito, M and Pea, M and Giovine, E and Notargiacomo, A and Ortolani, M and Di Gaspare, A and Baldi, A and Pizzolante, F and Ciasca, G},
  title = {Exploring novel circulating biomarkers for liver cancer through extracellular vesicle characterization with infrared spectroscopy and plasmonics},
  journal = {Analytica Chimica Acta},
  year = {2024},
  volume = {1319},
  pages = {342959},
  doi = {10.1016/j.aca.2024.342959}
}
Kostenlos starten →